BRANDON GEER: Open Payments
NPI 1649630096 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 21 payments from 7 companies in 2025. Trend: 2023 $665 · 2024 $375 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $430 |
| ABBVIE INC. | 2 | $250 |
| ABIOMED | 2 | $187 |
| Neurelis, Inc. | 1 | $117 |
| Phathom Pharmaceuticals, Inc. | 3 | $71 |
| Verona Pharma, Inc. | 2 | $52 |
| Astellas Pharma US Inc | 1 | $29 |
Products named: QULIPTA, Ozempic, Wegovy, VALTOCO, VOQUEZNA, Ohtuvayre, Rybelsus, Veozah.
Industry payments across NY — which companies pay providers there.
